首页|心力衰竭患者利尿剂抵抗诊断及管理中国专家共识

心力衰竭患者利尿剂抵抗诊断及管理中国专家共识

Chinese expert consensus for the diagnosis and management of diuretic resistance in patients with heart failure

扫码查看
利尿剂是住院心力衰竭(heart failure,HF)特别是急性失代偿心力衰竭(acute decompensated heart failure,ADHF)患者容量管理的基石.利尿剂抵抗(diuretic resistance,DR)表现为对利尿剂的反应减低甚至完全失效,不仅导致住院时间延长,还使病死率和再住院率增加.目前国内外尚缺乏对HF患者DR诊断和管理的共识.本共识梳理DR的定义、机制、诊断和管理等方面内容,并基于临床研究结果和专家经验,提出相应的处理建议,旨在提高临床医师对DR的认识,并规范DR治疗.
Diuretics play a crucial role in volume management for hospitalized patients with heart failure(HF),particularly those with acute decompensated HF(ADHF).Diuretic resistance(DR),manifested as a di-minished response or even a failure to diuretics,which not only prolongs in-hospital stay but also increases mortal-ity and rehospitalization.There is not yet a consensus regarding the diagnosis and management of DR in heart fail-ure patients.Therefore,this consensus focuses on elucidating the definition,mechanisms,diagnosis,and man-agement of DR.Based on clinical research findings and expert experiences,it offers recommendations for treat-ment,aiming to enhance physicians'awareness and standardize the management.

heart failurediuretic resistancevolume management

中国医师协会心血管内科分会、中国老年医学学会心电及心功能分会、中国心衰中心联盟专家委员会、杨杰孚、廖玉华、董蔚

展开 >

心力衰竭 利尿剂抵抗 容量管理

北京市自然科学基金-海淀原始创新联合基金

L222006

2024

临床心血管病杂志
华中科技大学心血管病研究所 华中科技大学协和医院

临床心血管病杂志

CSTPCD
影响因子:0.653
ISSN:1001-1439
年,卷(期):2024.40(4)
  • 70